CXCR7 antagonist-1 |
| カタログ番号GC63411 |
CXCR7 アンタゴニスト-1 は、SDF-1 ケモカイン (CXCL12 ケモカインとしても知られる) または I-TAC (CXCL11 としても知られる) のケモカイン受容体 CXCR7 への結合を阻害する CXCR7 アンタゴニストです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1613021-99-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CXCR7 antagonist-1 is an inhibitor of the binding of the SDF-1 chemokine (CXCL12 chemokine) or I-TAC (CXCL11) to the chemokine receptor CXCR. CXCR7 antagonist-1 prevents tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128)[1].
[1]. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1.
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *